Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

solutions

NULL

solutions (NULL) is an FDA-listed pharmaceutical active ingredient.

TGA: approved
Patents linked 20
Pipeline programs 2
News articles 1
Drug details — solutions
Class
—
Route
—
Patents
20
Programs
2
Data quality
0.78
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

solutions (NULL) is an FDA-listed pharmaceutical active ingredient.

Key facts

INN solutions
Brand NULL

Approval history

Authority Status Date
TGA approved —

Recent coverage

View all news
Axsome FDA Approval for Alzheimer's Agitation Drug
Critical impact Newsagitation associated with Alzheimer's diseaseMay 3, 2026

Axsome FDA Approval for Alzheimer's Agitation Drug

FDA · agitation associated with Alzheimer's disease · 6 min

Axsome Therapeutics has received FDA approval for a new treatment for agitation associated with Alzheimer's disease. This landmark decision addresses a critical unmet need and marks a significant step forward for the company and Alzheimer's patient care.

Dr. Priya Nandakumar

Pipeline programs

Browse pipeline
  1. CARDIOPLEGIA SOLUTIONS Approved · George Institute for · Cardiovascular pathology
  2. Shared Solutions® plus MS Center v. Shared Solutions® Approved · Teva Pharma · Multiple Sclerosis

Related patents

Browse patents

  1. US 12023410

    Micro/nanobubble solutions for tissue preservation and generation thereof

    Expires Mon Jun 27 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11872244

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Expires Mon Jan 11 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 11433038

    High concentration medicant solutions for treating neurological disorders

    Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 2020353106

    Stable, concentrated radionuclide complex solutions

    Expires Wed Nov 07 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 2020030465

    Stable, concentrated radionuclide complex solutions

    Expires Wed Jan 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 2020030466

    Stable, concentrated radionuclide complex solutions

    Expires Wed Jan 25 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10413566

    Thixotropic oxidized cellulose solutions and medical applications thereof

    Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10086114

    Antimicrobial solutions with enhanced stability

    Expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 9844530

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 9814695

    Ophthalmic solutions for glaucoma and conjunctivitis treatment

    Expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 9700509

    Solutions of lipophilic substances, especially medicinal solutions

    Expires Mon Jul 06 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 9637597

    DOPA-melanin formation in high ionic strength solutions

    Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 9565857

    Antimicrobial solutions

    Expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 9539330

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 9327031

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 9078441

    Antimicrobial flush solutions

    Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8952062

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Feb 05 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8859619

    Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy

    Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8709342

    Antimicrobial flush solutions

    Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8658694

    Buffer solutions having selective bactericidal activity against gram negative bacteria and methods of using same

    Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is solutions?

solutions (NULL) is an FDA-listed pharmaceutical active ingredient.

What is the brand name for solutions?

NULL is a marketed brand name for solutions. Check FDA Drugs@FDA for the current US label holder and prescribing information.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.